Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Imatinib Mesylate × 30 days × Clear all

Phase

Status

Active not recruiting 4 Recruiting 2 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 11 Nivolumab 7 Carboplatin 6 Specimen Handling 5 Pemetrexed 5 Biopsy 5 venetoclax 4 fludarabine 4 durvalumab 4 X-Rays 4 Paclitaxel 4 Magnetic Resonance Spectroscopy 4 Interviews as Topic 4 Gemcitabine 4 Cyclophosphamide 4 Cisplatin 4 binimetinib 3 atezolizumab 3 Surveys and Questionnaires 3 Radiotherapy 3 Radiosurgery 3 Prednisone 3 Drug Therapy 3 Docetaxel 3 toripalimab 2 tislelizumab 2 tazemetostat 2 spartalizumab 2 regorafenib 2 olaparib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00421317 2026-03-13

O-Mel-Inib

Centre Oscar Lambret

Phase 2 Terminated

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡